Tested Applications
| Positive IHC detected in | human lung tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
18043-1-AP targets IL-36 Beta/IL-1F8 in IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag12675 Product name: Recombinant human IL-1F8 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-157 aa of BC101833 Sequence: MNPQREAAPKSYAIRDSRQMVWVLSGNSLIAAPLSRSIKPVTLHLIACRDTEFSDKEKGNMVYLGIKGKDLCLFCAEIQGKPTLQLKEKNIMDLYVEKKAQKPFLFFHNKEGSTSVFQSVSYPGWFIATSTTSGQPIFLTKERGITNNTNFYLDSVE Predict reactive species |
| Full Name | interleukin 1 family, member 8 (eta) |
| Calculated Molecular Weight | 157 aa, 18 kDa |
| GenBank Accession Number | BC101833 |
| Gene Symbol | IL-36 Beta/IL-1F8 |
| Gene ID (NCBI) | 27177 |
| RRID | AB_2878487 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NZH7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for IL-36 Beta/IL-1F8 antibody 18043-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The IL-36 Beta/IL-1F8 Polyclonal antibody (Cat# 18043-1-AP) has 1 total citation. The citation appears in Experimental Dermatology (2025), a study examining clinical responses and transcriptomic analysis of spesolimab in a patient with severe dermatitis, multiple allergies, and metabolic wasting syndrome. The antibody was applied in IHC on human samples. The associated research field is dermatology and immunology, specifically focusing on IL-36-mediated inflammatory skin disorders and therapeutic intervention.
| Species | Application | Title |
|---|---|---|
Exp Dermatol Clinical Responses and Transcriptomic Analysis of Spesolimab in a Girl With Severe Dermatitis, Multiple Allergies and Metabolic Wasting Syndrome |



